Literature DB >> 34389889

CD8 + T Cells Exhibit an Exhausted Phenotype in Hemophagocytic Lymphohistiocytosis.

Madhura G Kelkar1, Umair Ahmad Bargir1, Reetika Malik-Yadav1, Maya Gupta1, Aparna Dalvi1, Neha Jodhawat1, Shweta Shinde1, Manisha R Madkaikar2.   

Abstract

PURPOSE: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome mainly caused by uncontrolled activation of antigen presenting cells and CD8 T cells. CD8 T cell exhaustion is a known phenomenon in chronic viral infections and cancer. However, the role of T cell exhaustion is not yet identified in HLH in the background of persistent inflammation. So, currently, we have characterized the CD8 T cells using flow cytometry to understand the phenomenon of exhaustion in these cells in HLH.
METHODS: We have comprehensively evaluated lymphocyte subsets and characterized CD8 T cells using immunophenotypic markers like PD1, TIM3, LAG3, Ki67, Granzyme B, etc. in a cohort of 21 HLH patients. Effector cytokine secretion and degranulation by CD8 T cells are also studied.
RESULTS: Our findings indicate skewed lymphocyte subsets and aberrantly activated CD8 T cells in HLH. CD8 T cells exhibit significantly increased expression of PD1, TIM3, and LAG3 prominently in primary HLH as compared to controls. PD1 + CD8 T cells express elevated levels of Granzyme B and Ki67. Moreover, CD8 T cells are hypofunctional as evidenced by significantly reduced cytokine secretion and compromised CD107a degranulation.
CONCLUSION: The study has revealed that CD8 + cytotoxic T lymphocytes from HLH patients exhibited high expression of exhaustion markers with overall impaired function. To the best of our understanding, this is the first report suggesting functional exhaustion of CD8 T cells in both primary and secondary HLH. Future studies to understand the association of exhaustion with disease outcome are needed for its probable therapeutic implementation.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Hemophagocytic lymphohistiocytosis; PD1; cytokine secretion; cytotoxic CD8 T lymphocytes; functional exhaustion

Mesh:

Substances:

Year:  2021        PMID: 34389889     DOI: 10.1007/s10875-021-01109-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  1 in total

1.  T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

Authors:  Vandana Chaturvedi; Rebecca A Marsh; Adi Zoref-Lorenz; Erika Owsley; Vijaya Chaturvedi; Trung C Nguyen; Jordana R Goldman; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Jeng; Ahmed Naqvi; Carl E Allen; Hector R Wong; Michael B Jordan
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

  1 in total
  1 in total

1.  The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.

Authors:  Yanxia He; Yan Gao; Liqin Ping; Haixia He; Cheng Huang; Bing Bai; Xiaoxiao Wang; Zhiming Li; Qingqing Cai; Yuhua Huang; Xueyi Pan; Wenbin Zeng; Yanan Liu; Huiqiang Huang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-09       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.